-
Product Insights
Nematodal (Round Worm) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Nematodal (Round Worm) Infections - Drugs In Development, 2023’, provides an overview of the Nematodal (Round Worm) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nematodal (Round Worm) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Helminthiasis (Parasitic Worm Infestation) – Drugs In Development, 2023
Global Markets Direct’s, ‘Helminthiasis (Parasitic Worm Infestation) - Drugs In Development, 2023’, provides an overview of the Helminthiasis (Parasitic Worm Infestation) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Helminthiasis (Parasitic Worm Infestation), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Track & Monitor
Innovation in automotive: Worm gear steering
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Worm gear steering segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Moxidectin in Helminthiasis (Parasitic Worm Infestation)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Moxidectin in Helminthiasis (Parasitic Worm Infestation) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Moxidectin in Helminthiasis (Parasitic Worm Infestation) Drug Details: Moxidectin is...
-
Product Insights
Onchocerciasis (River Blindness) – Drugs In Development, 2023
Global Markets Direct’s, ‘Onchocerciasis (River Blindness) - Drugs In Development, 2023’, provides an overview of the Onchocerciasis (River Blindness) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Onchocerciasis (River Blindness), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Intestinal Schistosomiasis Vaccine in Intestinal Schistosomiasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Intestinal Schistosomiasis Vaccine in Intestinal Schistosomiasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Intestinal Schistosomiasis Vaccine in Intestinal SchistosomiasisDrug Details:Vaccine candidate (SchistoShield) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TLL-041 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TLL-041 in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TLL-041 in Parkinson's Disease Drug Details: BHV-8000 (TLL-041) is under development...
-
Product Insights
Trifalga – Worms Innovation Center Development – Rheinland-Pfalz
Equip yourself with the essential tools needed to make informed and profitable decisions with our Trifalga - Worms Innovation Center Development - Rheinland-Pfalz report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Track & Monitor
Innovation in Automotive: Worm gears
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Worm gears segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – intestinal schistosomiasis vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry intestinal schistosomiasis vaccine Drug Details Vaccine candidate (SchistoShield) is under development for the prevention...